Semax
Men's HealthMen's-health clinics treat Semax as one component in a layered hormonal optimisation framework. A Russian-developed analogue of ACTH(4-10) extended with a Pro-Gly-Pro tail for proteolytic stability — a clinically used nootropic and stroke recovery agent. The relevant questions for male users are: does it interact with the HPG axis, is it compatible with current TRT or HCG protocols, and what are its effects on prostate, hematocrit, and cardiovascular indices over a CNS effect hours; plasma minutes-pharmacokinetics Semax cycle? The sections below address each.
Key Takeaways
Male-physiology lens: Semax is evaluated against HPG-axis interaction, TRT compatibility, and prostate / cardiovascular considerations. Mechanism: Elevates BDNF and NGF in hippocampus and cortex. Male monitoring: baseline testosterone (total/free), LH, FSH, estradiol, prolactin, SHBG; 6-8 week follow-up panel. Male dose: 300-2000 mcg per dose (varies) 2-4x daily for 10-14 day courses via intranasal; cycle 8-12 weeks. Male-physiology stack partners: Kisspeptin, Gonadorelin (GnRH), PT-141.
Elevates BDNF and NGF in hippocampus and cortex. Modulates dopamine and serotonin transporter expression. Inhibits enkephalinase, indirectly extending endogenous enkephalin action. Approved in Russia for stroke rehabilitation and cognitive disorders. For men, the downstream consequences of this mechanism are evaluated against four operational domains: HPG-axis interaction, recovery and body composition, sexual function and prostate, and integration with concurrent TRT or HCG protocols. Semax's relationship to each is examined below.
Male body composition and performance response
Male users typically respond to Semax on the recovery, lean-mass, or visceral-fat dimension depending on the compound's primary pharmacology. Elevates BDNF and NGF in hippocampus and cortex. Modulates dopamine and serotonin transporter expression. Inhibits enkephalinase, indirectly extending endogenous enkephalin action. Approved in Russia for stroke rehabilitation and cognitive disorders. For men whose body composition goals are driven by training, the dose-timing relative to workouts and sleep is often the critical lever rather than the absolute dose itself.
Sexual function and prostate considerations
Where Semax alters circulating LH, testosterone, or local androgen signalling, prostate considerations become relevant for men over 40. Baseline PSA, periodic re-check, and avoidance of stacking that compounds androgenic load are all reasonable precautions. For molecules whose effects are predominantly outside the HPG axis, the prostate consideration is largely background.
Compatibility with TRT and post-cycle protocols
For men currently on TRT or planning a post-cycle restart, Semax is typically compatible because it does not directly engage the HPG axis. The dominant interaction to watch for is on the metabolic and recovery layers rather than the hormonal layer. Where the molecule's pharmacology overlaps with HCG, gonadorelin, or kisspeptin, dose layering is the standard approach.
Where male users target hair loss, Semax is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
Body Composition (Male) in men responds to Semax with effect sizes that vary substantially by baseline status — men with documented suboptimal status respond more strongly than those at the upper end of normal. The protocol pattern in clinical use reflects this.
For prostate health in male users, Semax is most-effective when paired with comprehensive labs (testosterone total/free, LH, FSH, estradiol sensitive, prolactin, SHBG) at baseline and follow-up. Cycle length 8–12 weeks with re-evaluation.
Where male users target testosterone optimisation, Semax is typically integrated with the broader hormonal protocol — TRT, kisspeptin, gonadorelin, or HCG — rather than used in isolation. The integration approach varies by clinic.
| Goal | Route | Dose | Cycle |
|---|---|---|---|
| Standard protocol | Intranasal | 300-2000 mcg per dose (varies) | 8–12 weeks on / 4 weeks off |
| Conservative starter | Intranasal | 180-2000 mcg per dose (varies) | 4–6 weeks initial cycle |
| Men's Health focus | Intranasal | 300-2000 mcg per dose (varies) | 2-4x daily for 10-14 day courses |
| Maintenance phase | Intranasal | 210-2000 mcg per dose (varies) | Ongoing with periodic pauses |
Dose timing for Semax is important relative to food and training given the short half-life. Consistency through the cycle is more important than the precise clock time of individual doses.
Semax stacks well with compounds on complementary pathways. The pairings below are the conventional combinations from men's-health clinicians.
- Semax + Kisspeptin: Activates the KISS1R (GPR54) on GnRH neurons in the hypothalamus, triggering GnRH release. Pairs naturally with Semax's mechanism in male physiology protocols.
- Semax + Gonadorelin (GnRH): Binds the GnRH receptor on anterior pituitary gonadotrophs in a pulsatile fashion to stimulate LH (and to a lesser extent FSH) release. Pairs naturally with Semax's mechanism in male physiology protocols.
- Semax + PT-141: Activates MC4R in the hypothalamus and other CNS regions involved in sexual response. Pairs naturally with Semax's mechanism in male physiology protocols.
- Semax + Ipamorelin: Highly selective GHSR1a agonist. Pairs naturally with Semax's mechanism in male physiology protocols.
Excellent tolerability. Mild nasal irritation possible. No dependence.
Lens-specific safety considerations for male physiology use of Semax: Excellent tolerability. Mild nasal irritation possible. No dependence. Additional male physiology monitoring at baseline and 6–8 week follow-up is appropriate.
| Compound | Profile | Onset | Best For |
|---|---|---|---|
| Semax | ACTH-derived nootropic heptapeptide | CNS effect hours; plasma minutes | Men's Health |
| Kisspeptin | Hypothalamic upstream regulator of GnRH | ~28 min IV | The upstream master regulator of GnRH neurons — driving the entire HPG axis from above |
| Gonadorelin (GnRH) | Hypothalamic decapeptide | ~2-4 min | The natural decapeptide that drives pituitary release of LH and FSH — used clinically and increasingly as an HCG alternative during testosterone therapy |
| PT-141 | Melanocortin receptor agonist | ~2-3 hr | An MC3R/MC4R agonist derived from Melanotan II — FDA-approved as bremelanotide for HSDD in premenopausal women |
How does Semax affect the HPG axis?
Best time of day to dose for male users?
Will Semax affect fertility or sperm quality?
Does Semax affect hair, prostate, or erythrocyte production?
Is Semax safe during pregnancy or breastfeeding?
What is the regulatory status of Semax?
Start a Semax Protocol
Alukard provides physician-supervised men's health protocols with GMP-certified Semax and GMP-certified compounds with comprehensive hormone panels.
Get ProtocolQuick Facts
- Molecular weight
- 813 Da
- Sequence length
- 7 aa
- Half-life
- CNS effect hours; plasma minutes
- WADA
- Not on prohibited list
- FDA
- Unapproved (approved in Russia)
- Research
- Multi-decade Russian clinical use
All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Semax unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.
Start Your Male Physiology Protocol for Semax
Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.
HIPAA Compliant · GMP Certified · Physician Supervised